BioCentury
ARTICLE | Company News

Inhibitex, 3M deal

January 8, 2007 8:00 AM UTC

MMM received an exclusive worldwide license to INHX's ClfA protein target for developing diagnostics. MMM also received a license to additional INHX MCSCRAMM protein targets, which are located on the...